Refining the Definition of Polypharmacy and Its Link to Disability in Older Adults: Conceptualizing Necessary Polypharmacy, Unnecessary Polypharmacy, and Polypharmacy of Unclear Benefit

• Published in: Permanente journal Vol. 24; no. 1
• Main Authors: Lee, Eric A, Brettler, Jeffrey W, Kanter, Michael H, Steinberg, Steven G, Khang, Peter, Distasio, Christopher C, Martin, John, Dreskin, Mark, Thompson, Nolan H, Cotter, Timothy M, Thai, Kim, Yasumura, Lyn, Gibbs, Nancy E
• Format: Journal Article
• Language: English
• Published: United States The Permanente Journal 2020
• Subjects: Aged; Clinical Practice; Disabled Persons - statistics & numerical data; Drug Prescriptions - statistics & numerical data; Geriatric Assessment - methods; Humans; Polypharmacy; Prescription Drug Overuse - prevention & control; Prescription Drug Overuse - statistics & numerical data
• ISSN: 1552-5767; 1552-5775
• DOI: 10.7812/TPP/18.212

The term polypharmacy in older adults is generally used in a pejorative context in the medical literature. Because of its link to geriatric syndromes and disability, the avoidance of polypharmacy is usually recommended in older adults as a strategy to optimize functional status. However, there are many polypharmacy regimens based on high-quality trials that clearly reduce the risk of disability in older adults. Other guidelines for older adults recommend the use of additional medications that may or may not be evidence based and that may or may not reduce disability. Therefore, we propose that, in the geriatric literature, polypharmacy now be categorized as "necessary polypharmacy," "unnecessary polypharmacy," or "polypharmacy of unclear benefit." In this article, we discuss the 3 categories of polypharmacy and give examples on each polypharmacy regimen and its potential relationship to disability in older adults.